MARIEL CAIRO: Open Payments
NPI 1710537857 · CAPE CORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$631 in 30 payments from 16 companies in 2025. Trend: 2023 $78 · 2024 $1,029 · 2025 $631
Food & beverage: $631
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $135 |
| Novo Nordisk Inc | 2 | $50 |
| Sumitomo Pharma America, Inc. | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $45 |
| Amgen Inc. | 3 | $44 |
| Lilly USA, LLC | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 3 | $35 |
| Merck Sharp & Dohme LLC | 1 | $32 |
Products named: LINZESS, GEMTESA, JARDIANCE, OTEZLA, MOUNJARO, QULIPTA, VOQUEZNA, GARDASIL 9.
Industry payments across FL — which companies pay providers there.
